If You Invested $10,000 in Ocugen in December, This Is How Much You Would Have Today

If You Invested $10,000 in Ocugen in December, This Is How Much You Would Have Today

You might not have heard of Ocugen (NASDAQ: OCGN) a year ago. Ocugen soared more than 760% from January through a peak in February. The company partnered with India's Bharat Biotech to co-commercialize Bharat's near-to-market coronavirus vaccine in the U.S. So, if you were one of the early believers in this highflier, you watched your investment skyrocket.